Please login to the form below

Not currently logged in
Email:
Password:

Cirara

This page shows the latest Cirara news and features for those working in and with pharma, biotech and healthcare.

Biogen wins European spinal muscular atrophy first

Biogen wins European spinal muscular atrophy first

To that end it recently bought late-stage stroke candidate Cirara (glyburide) from Remedy Pharma and an anti-tau antibody from Bristol-Myers Squibb for Alzheimer's disease.

Latest news

  • Biogen hands out $120m upfront for Remedy stroke drug Biogen hands out $120m upfront for Remedy stroke drug

    Biogen hands out $120m upfront for Remedy stroke drug. Cirara vying to be first new treatment since the 1990s. ... Cirara (RP-1127) is an intravenous formulation of glyburide, a drug better known for its longstanding use as an oral treatment for type 2

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics